References

Czech and Slovak Ophthalmology

10.31348/2018/5/3

Original article

Changes of Central Corneal Thickness in Normotensive and Hypertensive Glaucoma

Lešták

Ján

https://orcid.org/0000-0001-9630-3441

Pitrová

Šárka

https://orcid.org/0000-0001-8472-9234

Nutterová

Elena

27 3 2019

The objective of the study was to determine whether there exists a difference in the central cornea thickness (CCT) in patients with hypertensive (HTG) and normotensive glaucoma (NTG), and subsequently, to compare the application of prostaglandins by corrected CCT (CCT correction) for both types of glaucoma. Material and methods: 100 eyes of 50 patients (the average age of 67) with HTG and 100 eyes of 50 patients (the average age of 62.6) with NTG were examined. Antiglaucomatics, if indicated, were taken by the patients for at least the preceding five years. The excluding criteria in the study were: cornea diseases, post-laser procedure conditions and high ametropia. CCT was measured by means of Tomey Handy Pachymeter SP100 by the same physician. Results: A two-sample t-test was applied in order to compare the measurement values of CCT and the subsequent correction of these values (CCT correction) in patients with HTG and NTG. The statistical evaluation showed that in case of both CCT and CCT correction, the values were lower in the group of NTG patients in comparison with HTG patients. With respect to CCT, the difference was statistically insignificant (NTG 554.9±35.7 vs. HTG 561.4 ± 32.7, p = 0.181). In case of CCT correction, the difference was more considerable, but still statistically insignificant (NTG 550.8 ± 35 vs. HTG 559.6 ± 33.1, p = 0.06). Conclusion: CCT was higher in NTG than in HTG; however, these values were statistically insignificant. A comparison of the application of prostaglandins of corrected CCT (CCT correction) for both types of glaucoma increased the difference, but this difference was still statistically insignificant. This difference was caused by an uneven representation of patients treated with prostaglandins in both groups.

hypertensive glaucoma normotensive glaucoma central cornea thickness prostaglandins

References

Bergonzi, C., Giani, A., Blini, M. et al.: Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy. J Glaucoma, 19; 2010: 617-621.

Copt, RP., Thomas, R., Mermoud, A.: Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol, 117; 1999: 14-16.

Grise-Dulac, A., Saad, A., Abitbol, O., et al.: Assessment of corneal biomechanical properties in normal tension glaucoma and comparison with open-angle glaucoma, ocular hypertension, and normal eyes. J Glaucoma, 21; 2012: 486-489.

Grüb, M., Leitritz, M., Mielke, J. et al.: Effect of timolol on central corneal thickness and endothelial cell density. Klin Monbl Augenheilkd. 223; 2006: 894-898.

Grüb M., Mielke, J., Schlote ,T., Rohrbach, M.: Effect of brimonidine on central corneal thickness. Klin Monbl Augenheilkd. 229; 2012: 236-240.

Grüb, M., Rohrbach, J.M.: Effect of timolol on central corneal thickness. Eur J Ophthalmol. 23; 2013: 784-788.

Harasymowycz, P.J., Papamatheakis, D.G., Ennis, M. et al.: Realtionship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea, 26; 2007: 34-41.

Hornová, J., Sedlák, P.: Pachymetrie u pacientů s glaukomem. Cesk Slov Oftalmol, 55; 1999: 212-215.

Kim, HJ., Cho, BJ.: Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma. J Ocul Pharmacol Ther, 27; 2011: 73-76.

Lee, JW., Wong, RL., Chan, JC. et al.: Differences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma. Int Ophthalmol, 35; 2015:67-72.

Lee, H., Cho, BJ.: Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results. J Ocul Pharmacol Ther, 31; 2015: 152-155.

Lestak, J., Nutterova, E., Pitrova, S. et al.: High Tension Versus Normal Tension Glaucoma. A Comparison of Structural and Functional Examinations. J Clinic Experiment Ophthalmol, 2012; 5.

Lešták, J., Pitrová, Š.: „Ganglion cells komplex“ a vrstva nervových vláken u hypertenzních a normotenzních glaukomů. Cesk Slov Oftalmol, 72; 2016: 199-203.

Liehneová, I., Karlovská, S.: Medikamentozní léčba glaukomu a biomechanické vlastnosti rohovky. Cesk Slov Oftalmol, 70; 2014: 167-176.

Maruyama, Y., Mori, K, Ikeda, Y. et al.: Effects of long-term topical prostaglandin therapy on central corneal thickness. J. Ocul. Pharmacol.Ther 30; 2014: 440-444.

Shetgar, AC., Mulimani, MB.: The central corneal thickness in normal tension glaucoma, primary open angle glaucoma and ocular hypertension. J Clin Diagn Res, 7; 2013: 1063-1067.

Schiote, T., Tzamalis, A., Kynigopoulos, M.: Central corneal thickness during treatment with travoprost 0,004% in glaucoma patients. J. Ocul. Pharmacol.Ther 25; 2009: 459-462.

Stefan, C., Dumitrica, D.M., Tebeanu, E., et al.: Prostaglandin analogues and central corneal thickness. Oftalmologia, 51;2007:96-99.

Ventura, AC., Böhnke, M., Mojon, DS.: Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension. Br J Ophthalmol, 85; 2001: 792-795.

Wu, LL., Suzuki, Y., Ideta, R.: Central corneal thickness of normal tension glaucoma patients in Japan. Jpn J Ophthalmol, 44; 2000: 643-647.

Wu, N., Chen, Y., Yu, X., et al.: Changes in corneal biomechanical properties after long-term topical prostaglandin therapy. PLoS One, 17; 2016: 11(5) :e0155527.

Yoo, R., Choi, YA., Cho, BJ.: Change in central corneal thickness after the discontinuation of latanoprost in normal tension glaucoma-change in central corneal thickness after stop of latanoprost. J Ocul Pharmacol Ther, 33; 2017: 57-61.

You, JY., Cho, BJ.: Effect of latanoprost on central corneal thickness in unilateral normal-tension glaucoma. J Ocul Pharmacol Ther, 29; 2013: 335-338.

Zhong, Y., Shen, X., Yu, J., Cheng, Y.: The comparison of the effects of latanoprost, travoprost, and bimatoprost on the central corbeal thickness. Cornea, 30; 2011: 861-864.